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Increasing evidences show that immune response affects the reparative mechanisms in injured brain. Recently, we have
demonstrated that CD4
þT cells serve as negative modulators in neurogenesis after stroke, but the mechanistic detail remains
unclear. Glucocorticoid-induced tumor necrosis factor (TNF) receptor (GITR), a multifaceted regulator of immunity belonging to
the TNF receptor superfamily, is expressed on activated CD4
þT cells. Herein, we show, by using a murine model of cortical
infarction, that GITR triggering on CD4
þT cells increases poststroke inﬂammation and decreases the number of neural stem/
progenitor cells induced by ischemia (iNSPCs). CD4
þGITR
þT cells were preferentially accumulated at the postischemic cortex,
and mice treated with GITR-stimulating antibody augmented poststroke inﬂammatory responses with enhanced apoptosis of
iNSPCs. In contrast, blocking the GITR–GITR ligand (GITRL) interaction by GITR–Fc fusion protein abrogated inﬂammation and
suppressed apoptosis of iNSPCs. Moreover, GITR-stimulated T cells caused apoptosis of the iNSPCs, and administration of
GITR-stimulated T cells to poststroke severe combined immunodeﬁcient mice signiﬁcantly reduced iNSPC number compared
with that of non-stimulated T cells. These observations indicate that among the CD4
þT cells, GITR
þCD4
þT cells are major
deterioratingmodulatorsofpoststrokeneurogenesis.Thissuggeststhatblockade oftheGITR–GITRLinteractionmaybeanovel
immune-based therapy in stroke.
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Braininjuryinducesacuteinﬂammation,therebyexacerbating
poststroke neuronal damage.
1–4 Although central nervous
system (CNS) is known for its limited reparative capacity,
inﬂammation is a strong stimulus for reparative mechanisms
including activation of neurogenesis. However, the latter
results in low survival of newly generated neural stem cells.
5
These ﬁndings indicate the relevance of endogenous
regulatory and/or environmental factors for survival and
differentiation of neural stem cells.
In a murine model of cerebral ischemia, we have detected
neural stem/progenitor cells induced by ischemia (ischemia-
induced neural stem/progenitor cells; iNSPCs) in the post-
stroke cerebral cortex.
6 More recently, we have observed
spontaneous accelerated repair in severe combined immuno-
deﬁcient mice (SCID) compared with immunocompetent
wild-type controls,
7 and have demonstrated that CD4
þT cells
serve as negative regulators in the survival of iNSPCs.
8
Together with previous reports supporting the importance of
the role of T cells in regulating poststroke inﬂammation
1,2,9
and functional recovery,
1,10,11 these ﬁndings emphasize on
the link between CD4
þT cells and survival of iNSPCs.
However, the mechanistic details and the subpopulation of
CD4
þT cells responsible for acting as negative regulators in
CNS repair remain unclear.
Glucocorticoid-induced tumor necrosis factor (TNF) recep-
tor (GITR)-related protein that was originally cloned in a
glucocorticoid-treated hybridoma T-cell line
12 is a protein
belonging to the TNF receptor superfamily. It is expressed at
basal levels in responder resting T cells, with CD4
þT cells
including CD4
þCD25
þT cells (regulatory T cell, Treg) having
a higher GITR expression than CD8
þT cells.
13 When the
T cells are activated, GITR is strongly upregulated in responder
CD4
þT cells. In this situation, the stimulatory effect of
responder T cells was more activated
13,14 and the suppres-
sing effect of Treg was completely abrogated,
13 leading to a
more enhanced immune/inﬂammatory response.
15 In the
CNS, it has been reported that blocking of the GITR–GITR
ligand (GITRL) interaction protected spinal cord injury from
Received 23.5.11; revised 06.9.11; accepted 27.9.11; Edited by JA Cidlowski; published online 04.11.11
1Laboratory of Neurogenesis and CNS Repair, Hyogo College of Medicine, 1-1 Mukogawacho, Nishinomiya, Hyogo 663-8501, Japan;
2Laboratory of Self Defense,
Institute for Advanced Medical Sciences, Hyogo College of Medicine, 1-1 Mukogawacho, Nishinomiya, Hyogo 663-8501, Japan;
3Department of Ophthalmology, Hyogo
College of Medicine, 1-1 Mukogawacho, Nishinomiya, Hyogo 663-8501, Japan and
4Department of Cerebrovascular Disease, National Cardiovascular Research
Center, Osaka 565-8565, Japan
*Corresponding author: T Matsuyama, Laboratory of Neurogenesis and CNS Repair, Institute for Advanced Medical Sciences, Hyogo College of Medicine,
1-1 Mukogawacho, Nishinomiya, Hyogo 663-8501, Japan. Tel: þ81 798 45 6821; Fax: þ81 798 45 6823; E-mail: tomohiro@hyo-med.ac.jp
5These authors contributed equally to this work.
Keywords: GITR; Fas; T-cell; neural stem cell; ischemia
Abbreviations: BrdU, 5-bromo-20-deoxyuridine; CNS, central nervous system; DAPI, 40,6-diamino-2-phenylindole; EGF, epidermal growth factor; FasL, Fas ligand;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GITR, glucocorticoid-induced tumor necrosis factor receptor; GITRL, GITR ligand; GFP, green ﬂuorescent
protein; gld, generalized lymphoproliferative disorder¼spontaneous mutation in the Fas ligand gene; iNSPC, ischemia-induced neural stem/progenitor cell; MCA,
middle cerebral artery; SCID, severe combined immunodeﬁcient; Sox2, SRY (sex determining region Y)-box 2; TCR, T-cell receptor; Treg, regulatory T cell
Cell Death and Differentiation (2012) 19, 756–767
& 2012 Macmillan Publishers Limited All rights reserved 1350-9047/12
www.nature.com/cddthe inﬂammatory response,
16 whereas GITR triggering
worsened experimental autoimmune encephalomyelitis while
stimulating autoreactive CD4
þT cells.
17 These observations
lead us to hypothesize that GITR triggering on T cells may
serve as a negative regulator for CNS repair after cerebral
infarction.
In this study, we demonstrated for the ﬁrst time that GITR
triggering on T cells following ischemic stroke enhanced
poststroke inﬂammation and cell death of iNSPCs. Adminis-
tration of GITR–Fc fusion protein markedly suppressed these
responses.Inaddition,GITR-triggeredTcellsdirectlyinduced
apoptosis of iNSPCs in vitro. Our current results show that
activated GITR
þT cells acted as negative modulators for
CNS restoration, indicating that blockade of the GITR–GITRL
interaction can be a novel strategy for treating ischemic
stroke.
Results
Inﬁltration of CD4
þGITR
þT cells into the ischemic
cortex after stroke. Immunohistochemistry (Figures 1a–c)
revealed that CD3
þ cells (T cells) appeared to inﬁltrate the
ischemic region as early as 3h after stroke (Figure 1b) and
were observed continuously during the poststroke period
(Figures 1d and g). The T cells were rarely observed at
nonischemic ipsilateral or contralateral cortex (Figure 1c).
Most T cells in the ischemic region (B70% of T cells) were
CD4 positive (Figures 1d–i), indicating that CD4
þT cells
predominantly inﬁltrate the poststroke cortex. However,
GITR-positive cells were not found in the ischemic region
at 6h after stroke (Figure 2a), whereas a number of T cells
were detected at the same region (Figures 2b and c). This
indicates that GITR was not expressed in the inﬁltrated
T cells at early poststroke period. GITR-expressing cells
started to appear at 24h after stroke and gradually increased
in number. At 7 days post stroke, a number of CD3
þT cells
co-express GITR (Figures 2d–f). Calculating the number of
inﬁltrated T cells in serial brain sections revealed that B65%
of CD4
þT cells were GITR positive, indicating that GITR
þ
T cells predominantly occupied the subset of CD4
þT cells at
the late poststroke period. Semiquantitative analysis for the
number of CD4
þT or GITR
þ cells in the ischemic region is
shown in Figure 2g.
Predominant accumulation of CD4
þGITR
þT cells at the
ischemic cortex after stroke. To conﬁrm the enhanced
expression of GITR on CD4
þT cells, we assessed the
subset of T cells by FACS analysis using the cells extracted
from the ischemic cortex
18 (Figures 3a and b). Consistent
with the previous report, the brain extract contained
substantial amount of mononuclear cells (Figure 3b) and
FACS analysis detected a distinct subset of lymphocytes that
had inﬁltrated the ischemic cortex (Figures 3c–f). We
detected about 20% CD4
þT cells extracted from the
infarcted brain tissue. We at ﬁrst gated CD3
þ cells and
then analyzed CD25 to characterize the corresponding
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CD3 CD3/CD4 1 day 1 day 1 day CD4
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Figure 1 T-cell inﬁltration into the ischemic area of the poststroke brain. Immunohistochemistry for CD3
þ cells (T cells; (a) B: ischemic area and C: contralateral cortex)
andCD4
þTcells(d–i)inﬁltratedintothepostischemiccortex3h(bandc),1day(d)and7days(g)afterstroke.CD3
þ TcellswerepositiveforCD41dayand7days(arrows,
d and g: CD3; e and h: CD4; f and i: merged, nuclei were counterstained with DAPI) after stroke. Arrowheads indicate CD4
  T cells (f and i). (b–i) Scale bar: 100mm
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Cell Death and DifferentiationCD4
þT cells. GITR was analyzed on CD3
þCD4
þ cells. No
signiﬁcant upregulation of CD25 on T cells was observed at
days 1 and 7 after stroke (Figures 3c and e: 4.61% at day 1
and 4.06% at day 7). However, the percentage of GITR
þ
T cells was increased from 6.17 to 86.50%, and the surface
expression of GITR on CD4
þT cells at day 7 was
signiﬁcantly increased compared with that at day 1 (from
13.90 to 68.37 in mean channel value; Figures 3d and f),
indicating enhanced expression of GITR as an activation
marker for CD4
þT cells.
Effects of GITR triggering on cerebral infarction. Given
that GITR triggering was involved in cerebral ischemic injury,
we decided to examine whether stimulation or inhibition of
GITR triggering affects cerebral infarction by using the same
stroke model. Mice were treated with anti-GITR agonistic
antibody (GITR–Ab: DTA-1), GITR–Fc fusion protein
(blocking the GITR–GITRL interaction) or control IgG at 3h
and 3 days after stroke. The brain was then removed 30 days
a f t e rs t r o k e .T h es i z eo fi n f a r c t i o ni nm i c et r e a t e dw i t hG I T R – A b
was apparently larger than that of mice treated with GITR–Fc
(Figure 4a). Further analysis of the volume of each
hemisphere based on brain sections demonstrated a
signiﬁcant decrease in the poststroke brain volume in
GITR–Ab mice, and a signiﬁcant increase in that of
GITR–Fc mice, compared with control mice (Figure 4b).
These ﬁndings indicated that ischemic injury was enhanced
by GITR triggering, while ameliorated by its blocking.
Effects of GITR triggering on poststroke inﬂammation.
. We had until then attempted to determine how the triggering
of GITR could affect poststroke inﬂammation. As several
studies have reported that multiple cytokines modulate CNS
inﬂammation,
2,3,19 the levels of IFN-g, TNF-a and IL-10 were
analyzed using quantitative real-time PCR in mice 7 days
after stroke. The alteration of mRNA levels of these cytokines
within the ischemic region was conﬁrmed (Figure 4c–e).
GITR–Ab treatment resulted in a signiﬁcant elevation of
IFN-g (Po0.05) and TNF-a (Po0.05) levels, and a signiﬁcant
decrease in the IL-10 level (Po0.01) compared with the
control IgG treatment. In contrast, treatment with GITR–Fc
showed a signiﬁcant decrease in IFN-g (Po0.01) and TNF-a
levels (Po0.05), and a signiﬁcant increase in IL-10
level (Po0.01) compared with the control. These data
indicated that GITR triggering largely affected cerebral
ischemic injury by changing the level of poststroke
inﬂammation (enhancing proinﬂammatory cytokines and
suppressing anti-inﬂammatory cytokines).
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Figure 2 GITR-positive T-cell inﬁltration into the ischemic area of the poststroke brain. Immunohistochemistry for GITR
þT( a–f) cells inﬁltrated into the postischemic
cortex6h(a–c)and7days(d–f)afterstroke.TheTcellswerenegativeforGITRat6h(a:GITR;b:CD3;c:merged),butappearedtobepositiveforGITRat7days(arrows,d:
GITR; e: CD3; f: merged). Arrowheadsindicate GITR
  T cells (f). (a) Scale bar: 100mm. (g) Cells expressingCD3 (gray bars), CD4 (white bars) or GITR(black bars) 3h, 6h,
24h, 3 days or 7 days after stroke were quantiﬁed. Results displayed are representative of three repetitions of the experimental protocol
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Figure3 TheanalysisforthesubpopulationofinﬁltratedcellsintheischemicareawithFACS.(a)Theischemictissueofthebrain7daysor1dayafterstrokewasisolated
and pressed through a cell strainer, and was separated by Ficoll-paque plus centrifugation. The extract contains lymphocyte-like mononuclear cells, which were observed
under phase-contrast microscope. (b) FACS analysis for the subset of T cells that inﬁltrated the ischemic cortex was performed. The acquired lymphocytes were analyzed for
CD4
þ and CD25
þ on CD3
þ cells 1 day (c) and 7 days (e), and for GITR on CD3
þCD4
þ cells 1 day (d) or 7 days (f) after stroke. The percentage of CD25
þ cells was
evaluatedinthetotalTcells(CD3
þ cells),andthatofGITR
þ cellswasevaluatedinCD4
þ T(CD3
þCD4
þ)cellsextractedfromtheinfarctedbraintissue.Themeanchannel
values were displayed for GITR in the CD3
þCD4
þ cells. (d and f) Filled histogram represents GITR expression and open histogram represents isotype control
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Figure 4 Effects of GITR triggering on the poststroke brain volume and cytokine expression. (a) On day 30 after stroke, brains of mice treated with either GITR–Ab or
GITR–Fc were evaluated grossly. Areas of hatched line indicate infarct area. (b) Ipsilateral and contralateral cerebral hemisphere volume was calculated by integrating
coronally oriented ipsilateral and contralateral cerebral hemisphere area. Involution of ipsilateral cerebral hemisphere volume calculated as (ipsilateral/contralateral cerebral
hemisphere volume) conﬁrmed a signiﬁcant difference in brain volume in the poststroke hemisphere comparing the groups. (b) n¼5 for each experimental group. (a) Scale
bar:2mm.TheexpressionofIFN-g(c),TNF-a(d)andIL-10(e)intheischemictissueonday7afterstrokewasdetectedbyquantitativereal-timePCR.Therelativeexpression
of mRNAs was represented as arbitrary unit, which was set at the level of the expression of the gene equal to 1 in the IgG-treated group using a logarithmic scale. The
signiﬁcance among the treatments was calculated from the relative level of mRNA expression. (c–e) n¼4 for each experimental group. *Po0.05 and **Po0.01, GITR–Ab-
treated mice versus control IgG-treated mice;
#Po0.05 and
##Po0.01, GITR–Fc-treated mice versus control IgG-treated mice
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Cell Death and DifferentiationEffects of GITR triggering on survival/death of neural
stem/progenitor cells. Inﬂammation is known not only as a
deteriorated factor of cerebral injury but also as a strong
stimulator of neurogenesis. As the current study has proved
that GITR triggering can regulate the inﬂammatory
response,
15,17 we assessed the GITR–GITRL interaction,
which may contribute to neurogenesis in the infarction area.
Because we had previously showed that iNSPCs could
contribute to poststroke neurogenesis and that cortical
neurogenesis is related to the development of the
iNSPCs,
8,20,21 the effects of GITR–Ab or GITR–Fc on
survival/death of iNSPCs were investigated by using
immunohistochemistry for nestin and active caspase-3 on
the ischemic brain sections. The nestin-positive iNSPCs
were observed at the border of the infarction as well as in the
ischemic core 7 days after stroke (see Supplementary Figure
1B, red, nestin) as described.
6,8,20 Control IgG-treated mice
appeared to have abundant nestin and active caspase-3
double-positive cells (Figure 5a, red, nestin; green, caspase-3).
The administration of GITR–Ab increased the number of
nestin/caspase-3 cells (Figure 5b), whereas that of GITR–Fc
decreased it (Figure 5c). The number of activated caspase-3-
positive iNSPCs was signiﬁcantly different among the three
groups (Figure 5d; **Po0.01, GITR–Ab versus control IgG;
#Po0.05, GITR–Fc versus control IgG). These ﬁndings
indicate that GITR triggering induced, whereas its blocking
suppressed, apoptosis of iNSPCs.
To provide further support for our hypothesis that GITR
triggering participates in iNSPC-death/survival, expressions
of nestin and Sox2 (SRY (sex determining region Y)-box 2),
neural stem cells markers,
22 were assessed by immunohisto-
chemistry (Figures 5e–h). Seven days after stroke, a
number of nestin-positive cells express Sox2, especially at
the border of infarction (Supplementary Figures 1A–D). The
administration of GITR–Ab signiﬁcantly decreased the
number of nestin/Sox2 double-positive cells (Figures 5f and
h; Po0.01 versus control IgG), whereas the administration of
GITR–Fc increased them (Figures 5g and h; Po0.01 versus
control IgG). These ﬁndings were conﬁrmed by conventional
reverse transcription (RT)-PCR (Figures 5i–k) using mRNA
extracted from the infarcted cortex (Figure 5i). Relative
expressions of nestin and Sox2 were attenuated by
GITR–Ab treatment, and enhanced by GITR–Fc treatment
(Figures 5j and k; Po0.01, among the three groups).
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Figure 5 Effectsof GITR–Abor GITR–Fcon survival/deathof neuralstem/progenitorcells.(a–d)Co-expression ofnestin(red)andactivecaspase-3(green;arrowheads)
was investigated 3 days after stroke at the border of the infarction. Compared with the control IgG-treated mice (a), GITR–Ab-treated mice showed an increased number of
nestin/caspase-3-positive cells (b), whereas GITR–Fc-treated mice showed fewer co-expressing cells (c). (e–h) Co-expression of nestin (red) and Sox2 (green; arrowheads)
was investigated 7 days after stroke. Few cells co-expressing nestin and Sox2 were observed in GITR–Ab-treated mice (f), whereas a number of nestin/Sox2-co-expressing
cells were observed in GITR–Fc-treated mice (g). The number of nestin/caspase-3 cells (d) and nestin/Sox2 cells (h) at each period was signiﬁcantly different on comparing
the groups. (d) n¼3 and (h) n¼4 for each experimentalgroup. (i–k) Expression of nestin or Sox2 was detected by conventional RT-PCR in the ischemic tissue on day 7 (i).
Compared with the control IgG-treated mice (ﬁrst lane), GITR-treated mice showed decreased expression of nestin or Sox2 (second lane), whereas GITR–Fc-treated mice
showed increased expression (third lane). The relative expression was signiﬁcantly different on comparing the groups (j: nestin; k: Sox2). (j) n¼4 and (k) n¼5 for each
experimental group. (a) Scale bar: 100mm. **Po0.01, GITR–Ab-treated mice versus control IgG-treated mice;
#Po0.05 and
##Po0.01, GITR–Fc-treated mice versus
control IgG-treated mice
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Cell Death and DifferentiationEffects of GITR-stimulated T cells on survival/death of
neural stem/progenitor cells. As the ischemic insult
enhanced the expression of GITR on inﬁltrated CD4
þ
T cells (Figures 1–3) and GITR triggering disrupted iNSPCs
in poststroke mice (Figure 5), we next investigated whether
GITR-triggered, activated CD4
þT cells could affect survival/
death of iNSPCs. Activation of CD4
þT cells by ligation of
GITR has been reported previously,
17 and we also conﬁrmed
enhanced expression of GITR on CD4
þT cells by GITR–Ab
(DTA-1; see Figure 8d; lanes 3, 4). Initially, to conﬁrm
inﬁltration of the administered T cells into the ischemic area,
T cells extracted from the green ﬂuorescence protein-
transgenic (GFP-Tg) mice were injected into SCID mice
2 days after stroke as described previously.
7,20 Five days
after administering, the GFP-positive T cells migrated
selectively into the infarction area of the poststroke brain
(Supplementary Figure 2). Next, we injected T cells of CB-17
mice (either stimulated or non-stimulated by GITR–Ab) as
described above, and examined the expressions of nestin/
Sox2 double-labeled cells 5 days after injection by
immunohistochemistry (Figures 6a–d). In accordance with
our previous report,
8 poststroke SCID mice with PBS
injection (control) expressed a greater number of nestin/
Sox2-positive iNSPCs than CB-17 mice (compare Figure 6d
with Figure 5h). The administration of GITR-stimulated
T cells signiﬁcantly decreased the number of nestin/Sox2
cells (Figures 6b and d; Po0.01), whereas non-stimulated
T cells had no signiﬁcant effect (Figures 6c and d). These
ﬁndings were conﬁrmed by conventional RT-PCR analysis
(Figure 6e). Relative expressions of both nestin and Sox2
were attenuated by administration of GITR-stimulated T cells
but not by non-stimulated T cells (Figures 6f and g). The
proliferation of iNSPCs was also evaluated by labeling of
nestin-positive cells with bromodeoxyuridine (BrdU), as per a
previous report.
8 GITR-stimulated T cells signiﬁcantly
decreased the number of BrdU-labeled nestin-positive cells
compared with PBS treatment as a control (Figures 6i and k;
Po0.01), whereas non-stimulated T cells had no signiﬁcant
effect (Figures 6j and k). These ﬁndings indicate that GITR-
triggered, activated CD4
þT cells, but not non-stimulated
T cells, affect survival/death of iNSPCs after stroke.
In vitro effects of TNF-a and Fas ligand on apoptosis of
neural stem/progenitor cells. To determine how activated
CD4
þT cells ligated by GITR affect survival/death of
iNSPCs, a cell death assay was performed using cultured
neurospheres consisting of iNSPCs (Figure 7a). It is well
known that some neural stem/progenitor cells undergo
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Figure 6 Effects of administration of T cells triggered by GITR on survival/death of neural stem/progenitor cells. (a–d) Co-expression of nestin (red) and Sox2 (green;
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Cell Death and Differentiationapoptosis, with expression of multiple cell death signals such
as TNF receptor-1 (TNFR-1)
23 and Fas.
8 Consistent with
these studies, we conﬁrmed expression of TNFR-1
(Figure 7b) and Fas (Figure 7c) on iNSPC neurospheres.
The neurospheres were incubated with Dulbecco’s modiﬁed
Eagle’s medium (DMEM) containing TNF-a or agonistic Fas
antibody (Jo-2) for 24h, and their apoptosis was analyzed by
Annexin V staining and active caspase-3 assay. As
expected, TNF-a induced apoptosis of neurosphere cells
(Figure 7d; green: Annexin V, red: PE). The activity of
caspase-3 in the apoptotic neurosphere was increased dose
dependently by TNF-a (Figure 7g). Jo-2 also induced
apoptosis of neurospheres (Figure 7e), with a signiﬁcant
increase in caspase-3 activity (Figure 7h). Because iNSPCs
neurosphere do not express GITR (Figure 7f), it is not likely
that GITR signaling regulates death-receptor-induced
apoptosis directly in iNSPCs. Accordingly, neither GITR–Ab
nor GITR–Fc activated caspase-3 on the neurospheres
(Figure 7i). These ﬁndings suggest that the death signaling
pathway may be stimulated either directly or indirectly by
activated CD4
þT cells ligated by GITR. Moreover, these
results also prove that the triggering of GITR directly have no
effect on apoptosis of iNSPCs.
Effect of GITR-stimulated Gld-T cells on survival/death
of neural stem/progenitor cells. To assess the action
of activated T cells, neurospheres were incubated with
T cells (either GITR stimulated or non-stimulated) for 24h
(Figures 8a and b). Consistent with previous studies,
16,24
T cells stimulated by GITR–Ab showed upregulation of Fas
ligand (FasL) expression (Figures 8c and d; lanes 3 and 4) as
well as GITR expression (Figure 8d; lanes 3 and 4). Annexin V
staining showed that neurospheres coincubated with
GITR-stimulated T cells underwent apoptosis (Figure 8a),
but those with non-stimulated T cells did not (Figure 8b). This
result strongly suggested a role of FasL expressed on T cells
in the iNSPCs apoptosis. Because nestin-positive iNSPCs
were frequently observed in close association with
endothelial cells
20,21 and CD4
þT cells (Supplementary
Figure 3) in the poststroke brain, it is highly possible that
activated T cells induce apoptosis of iNSPCs by cell to cell
interactions.
To conﬁrm this hypothesis in vivo, we administered T cells
from the FasL-deﬁcient (generalized lymphoproliferative
disorder¼spontaneous mutation in the Fas ligand gene;
gld) mice,
25 stimulated by GITR–Ab, to poststroke SCID mice
and analyzed the expression of nestin and Sox2 in the
postischemic area by conventional RT-PCR. As gld-T cells
stimulated by GITR–Ab showed enhanced GITR expression
compared with non-stimulated gld-T cells similar to T cells
from wild-type mice (Figure 8d; lanes 1 and 2, Figure 8f), the
injected T cells were considered to be activated without
**
TNF-α Jo-2
Nestin/DAPI TNFR-1/DAPI Fas/DAPI
GITR
GAPDH
iNSPCs
**
**
T cell
Figure 7 Involvement of death factors in apoptosis of iNSPCs neurospheres. In neurospheres obtained from the ischemic areas of poststroke mice, nestin (green; a),
TNFR-1 (red; b) and Fas (red; c) were virtually observed (DAPI, blue). Incubation with TNF-a (d) or Jo-2 (e) induced collapse of cell clusters with expression of a marker of
apoptotic cell death, anionic phosphatidylserine visualized with Annexin V staining (green). (f) GITR was not expressed on iNSPCs neurosphere. (g) Incubation with TNF-a
increased the activity of caspase-3 in neurospheres in a dose-dependent manner. Jo-2 also increased the activity (h), but neither GITR–Ab (DTA-1) nor GITR–Fc activated
caspase-3on theneurospheres(i).(a and d)Scale bar:100mm. (g–i)n¼3 for eachexperimental group. **Po0.01 versuscontrol groups(g: without TNF-a; h: CHZwithout
Jo-2). No signiﬁcant difference was found among the groups (i)
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Cell Death and Differentiationexpression of FasL (Figure 8e). Although administration of
GITR-stimulated T cells from wild mice (C57/B6) signiﬁcantly
attenuated nestin and Sox2 expression (Figure 8g; lanes 3
and 4), administration of GITR-stimulated gld-T cells had no
signiﬁcant effect (Figure 8g; lanes 1 and 2). Relative
expressions of nestin and Sox2 were attenuated only by
GITR-stimulated wild-type T cells from wild mice, but not by
GITR-stimulated gld-T cells or non-stimulated T cells (Figures
8h and i; Po0.01, among the ﬁve groups). These ﬁndings
indicate that GITR-triggered activated CD4
þT cells directly
induce Fas-mediated apoptosis of iNSPCs through possible
cell to cell interactions.
Discussion
This study clearly demonstrated a key role of GITR triggering
in regulation of neurogenesis after stroke, thereby delineating
the contribution of activated T cells expressing GITR to the
survival of neural stem/progenitor cells in the poststroke
cortex. Because a subset of CD4
þT cells mainly expresses
GITR after stroke, it is likely that activated CD4
þT cells
triggered by GITR are harmful to the new-born cells. The
current study also suggests possible mechanisms involving
FasL- and TNF-a-induced cell death signals, suggesting
interactions between iNSPCs and GITR-triggered T cells,
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Figure 8 Involvement of Fas ligand expressed on the surface of T cells in survival/death of neural stem/progenitor cells. Incubation with GITR-stimulated T cells induced
apoptotic cell death on neurospheres determined by Annexin V staining (a: green), whereas no cell death was observed in the presence of non-stimulated T cells (b). The
upregulatedFasLexpressedonGITR-stimulatedTcellswasconﬁrmedbyFACSanalysis(c:redlineindicatestheFasLexpressiononGITR-stimulatedTcells,andgreenline
on non-stimulated T cells in CD4
þ T cells). The mean channel values were displayed for FasL in the CD4
þ T cells. Conventional RT-PCR showedthat T cells obtained from
Gldmice(Gld-Tcell)neverexpressedFasligandevenafterGITRstimulation(d:lanes1and2;e),whereasTcellsofwildC57/B6miceexpressedit(d:lanes3and4;e).GITR
stimulation upregulated GITR on T cells regardless of the presence of FasL (d: lanes 1 and 3; f). The group of GITR-stimulated T cells from C57B/6 only signiﬁcantly
upregulated FasL (dand e). (a) Scale bar:100mm. (e andf) n¼5 for each experimental group. **Po0.01 versusGld-T cell groupsor non-stimulatedT (GITR–Ab( )/C57B/
6-T) cell group. Expression of nestin or Sox2 detected by conventional RT-PCR in the ischemic cortex of SCID mice 7 days after stroke was not affected by administration of
Gld-T cells stimulated by GITR–Ab (g: ﬁrst versus second lanes; h and i), although it was signiﬁcantly decreased after treatment with wild-type (C57B/6) T cells stimulated by
GITR-Ab (g: third versus fourth lanes; h and i). The relative expression of nestin or Sox2 was signiﬁcantly suppressed only in the case of mice administered with FasL-
expressed T cells stimulated by GITR–Ab. (h and i) n¼5 for each experimental group. **Po0.01 versus Gld-T cell groups, GITR( )/C57B/6-T-cell group or PBS group. No
signiﬁcant difference was found among the other groups
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Cell Death and Differentiationwith the latter serving as negative regulators for CNS repair
after cerebral infarction.
GITR was originally cloned from a glucocorticoid-treated
hybridoma T-cell line as a TNF-receptor-like molecule
induced by glucocorticoid-sensitive T cells.
12 GITR is now
considered to be upregulated in T cells by T-cell receptor
(TCR)-mediated activation.
26 As GITR-expressing T cells are
resistant to glucocorticoid-induced cell death, it has been
proposed that GITR, in conjunction with other TCR-induced
factors, protects T cells from apoptosis.
26 In fact, GITR can be
upregulated by viral infection
27 or acute lung inﬂammation.
15
In the present study, we have demonstrated for the ﬁrst time
that GITR is upregulated in T cells by ischemic insult to the
brain, although previous reports have shown the role of GITR
in ischemic damage on the kidney or the intestine.
28,29
Consistent with our previous study,
8 CD4
þT cells pre-
dominantly migrated to the infarcted brain after stroke. The
high number of GITR
þCD4
þT cells suggested that activated
T-cell proliferation contributed to the poststroke inﬂammatory
response. GITR has been reported to enhance the secretion
of proinﬂammatory cytokines, such as IL-2 and IFN-g, from
GITR
þT cells.
30 In contrast, GITR triggering on
CD4
þCD25
þTreg completely abrogates the suppressing
effect of Treg,
13 which normally secrete anti-inﬂammatory
cytokinessuchasIL-10.
31 Thus,we suggestthatupregulation
of the GITR expression in the brain can aggravate T-cell-
mediated poststroke inﬂammation. The present study demons-
trated that GITR triggering in poststroke mice enhanced, and
its blocking ameliorated the poststroke inﬂammatory
response as indicated by modulation of cytokines, such as
IFN-g, TNF-a and IL-10. These data suggest that T-cell-
mediated poststroke inﬂammation can be modulated by the
immune response deriving from GITR–GITRL interaction.
It is well known that cerebral injury induces a disturbance of
the normally well-balanced interplay between the immune
system and the CNS.
32 This process results in homeostatic
signalsbeingsenttovarioussitesinthebodythroughpathways
of neuroimmunomodulation, including hypothalamic–pituitary–
adrenal (HPA) axis. Activation of the HPA axis results in the
productionofglucocorticoidhormones.Althoughglucocorticoid
does prevent inﬂammation by suppressing production of many
proinﬂammatory mediators, including cytokines such as IL-1b
and TNF-a,italso induces apoptosisinimmatureand matureT
lymphocytes.
33 The latter may in turn lead to secondary
immunodeﬁciency.
32 Alternatively, surviving T cells that are
resistant to glucocorticoid stress express GITR and may
contribute to the aggravation of inﬂammation.
Inﬂammation in neural tissue has long been suspected to
have a role in stroke. Immune inﬂuence on adult neural stem
cell regulation and function has also received much attention.
Although the details of immune signaling in the CNS are not
known, the impact of inﬂammatory signaling on adult
neurogenesis is known to be focused on the activation of
microglia as a source of proinﬂammatory cytokines, such as
TNF-a, IL-6 and IL-1b. We and others
34 have proved that
neural stem cells undergo apoptosis by TNF-a in vitro,
suggesting that TNF-a has a negative effect on poststroke
neurogenesis.Recent publicationhasrevealedthatGITRand
GITRL are functionally expressed on brain microglia, and that
thestimulationofGITRLcaninduceinﬂammatoryactivationof
microglia.
35 However, as iNSPCs never expressed GITR, it is
more likely that microglia contribute to iNSPC cell death
indirectly via TNF-a, which is secreted from the activated
microglia. We also propose that IFN-g produced by activated
GITR
þT cells stimulates microglia production of high levels of
TNF-a to induce apoptosis of iNSPCs through TNFR-1. It also
has been reported thatTNF-related apoptosis-inducing ligand
(TRAIL) has an important role in developing CNS injury, and
that anti-TRAIL treatment prevents GITR expression induced
by spinal cord injury.
36 As GITR-deﬁcient mice showed
attenuated TRAIL expression after SCI, blocking the GITR–
GITRL interaction by GITR–Fc protein may protect from the
inﬂammatory response via TRAIL-activated pathways.
In addition to cytokine effects on neurogenesis, we also
proposed the Fas-mediated pathway that affects poststroke
neurogenesis, as another target of immune signaling. Our
previous study
8 had shown that Fas-positive iNSPCs under-
went apoptosis in the poststroke cortex. The current study
conﬁrmed that GITR
þT cells expressing FasL triggered
apoptosis of iNSPC in vitro and reduced the expression of
nestin and Sox2 in the poststroke brain. These ﬁndings
suggest that activated T cells act on Fas-expressing iNSPCs
viacell tocell interactions in the poststrokebrain, although it is
very difﬁcult to prove the functional contact between iNSPCs
and Fas-expressing T cells in vivo. As nestin-positive iNSPCs
are in close association with endothelial cells
20,21 where
CD4
þT cells are inﬁltrated (Supplementary Figure 3), it is
possible that activated T cells are in contact with neural stem/
progenitor cells when the endothelial cells are damaged by
ischemic insult. Although another system that activates
neurogenesis through soluble FasL and Fas receptor
in conventional neurogenic regions has been previously
reported,
37 the current study may prove that the membrane-
bound FasL expressed on T cells is essential for Fas-induced
apoptosis.
38
Recent study has proposed the contribution of Tregs in
prevention of secondary infarct growth.
2,4 Because IL-10
signaling was mainly produced by CD4
þCD25
þTregs and
proinﬂammatory cytokines were downregulated in brains of
IL-10 transgenic mice, Tregs apparently contribute to the
anti-inﬂammatorysystemafterstroke.AlthoughGITR
þTcells
are known to belong to Tregs, a recent study has emphasized
that GITR is a marker for activated effector T cells.
39 The
CD4
þCD25
  T-cell-derived GITR
þ cells (GITR
þ non-Treg)
are also known to activate self-reactive T cells by attenuating
the function of Tregs,
13 indicating that they may harm the
living cells by eliciting autoimmunity.
13,24 We demonstrated in
thecurrentstudythatblocking theGITR–GITRLinteractionby
GITR–Fc protein increased IL-10 expressionin the poststroke
cortex, suggesting that blocking such interactions enhanced
TregfunctionaswellasinhibitionofeffectorTcellfunction.On
thebasisoftheseﬁndings,thepresentstudysuggeststhatthe
novel therapies for stroke may ultimately include GITR-
targeted manipulation of immune signaling.
Materials and Methods
All procedures were carried out under auspices of the Animal Care Committee of
Hyogo College of Medicine, and were in accordance with the criteria outlined in the
‘Guide for the Care and Use of Laboratory Animals’ prepared by the National
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Cell Death and DifferentiationAcademy of Science. Quantitative analyses were conducted by investigators who
were blinded to the experimental protocol and identity of the samples under study.
Induction of focal cerebral ischemia. Male, 5- to 7-week-old, CB17/
Icr
þ/þ Jclmice(CB-17mice;CleaJapan Inc.,Tokyo,Japan) andCB-17/Icr
scid/scid
Jcl mice (SCID mice; CLEA Japan Inc.) were subjected to cerebral ischemia.
Permanent focal cerebral ischemia was produced by ligation and disconnection of
thedistal portion of theleft middle cerebral artery (MCA), as described in a previous
study. In brief, the left MCA was isolated, electrocauterized and disconnected just
distal to its crossing of the olfactory tract (distal M1 portion) under halothane
inhalation. The infarcted area in mice of this background has been shown to be
highly reproducible and limited to the ipsilateral cerebral cortex. Permanent MCA
occlusion (MCO) is achieved by coagulating the vessel. In sham-operated mice,
arteries were visualized but not coagulated.
Immunohistochemistry. To histochemically analyze the infarcted cortex,
mice were deeply anesthetized with sodium pentobarbital and perfused
transcardially with 4% paraformaldehyde. Brains were then removed, and coronal
sections (14mm) were stained with mouse antibodies against nestin (Millipore,
Billerica, MA, USA; 1/100), Sox2 (Millipore; 1/100), NeuN (Millipore; 1/200), rabbit
antibodies against caspase-3 active (R&D systems, Minneapolis, MN, USA; 1/100),
CD3 (AnaSpec, San Jose, CA, USA; 1/100), CD31 (Santa Cruz Biotechnology,
SantaCruz,CA,USA;1/100),ratantibodyagainstCD4(Biolegend,SanDiego,CA,
USA; 1/100) and GITR (eBioscience, San Diego, CA, USA; 1/100). As secondary
antibodies, Alexa Fluor 488 or Alexa Fluor 555 goat anti-mouse, -rabbit or -rat IgG
(Invitrogen, Carlsbad, CA, USA; 1/500) was used. Cell nuclei were stained with 40,
6-diamino-2-phenylindole ( DAPI, Kirkegaard & Perry Laboratories, Gaithersburg,
MD,USA;1/500).ThenumberofnestinandSox2double-positivecellsattheborder
ofinfarctions,includingtheinfarcted andperi-infarctedareas(0.5mm inwidth), was
counted under a laser microscope (Olympus Corporation, Tokyo, Japan).
To perform quantitative analysis of T cells, all CD3–, CD4– or CD3–GITR-
double-positive cells within the infarcted area were counted in the brain sections
obtained from CB-17 mice at 3h, 6h, 24h, 3 days and 7 days after stroke.
Furthermore, active caspase-3 and nestin double-positive cells within the infarcted
area were counted in the brain sections at 3 days after stroke. To investigate cell
proliferation at 7 days after stroke, BrdU (Sigma-AldrichCorporation,St. Louis, MO,
USA; 50mg/kg) was administered 6h before ﬁxation. Tissue was pretreated with
2N HCl for 30min at 371C and 0.1M boric acid (pH 8.5) for 10min at room temper-
ature, and then stained with antibody against BrdU. Next, the number of positive
cells for each marker was determined using modiﬁed Image J (National Institute of
Mental Health, Bethesda, MD, USA) as per a previous report.
8 Results were
expressed as the number of cells/mm
2.
The expression of Fas and TNFR-1 for neurosphere. To study the
expression of Fas and TNFR-1in the neurosphere in vitro, immunochemistry was
performedwithrabbitantibodyagainstFas(WakoPureChemicalIndustries,Osaka,
Japan; 1/100) or TNFR-1 (Santa Cruz Biotechnology; 1/100). As secondary
antibodies, Alexa Fluor 488 or Alexa Fluor 555 goat anti-mouse IgG (Invitrogen;
1/500) was used. Cell nuclei were stained with DAPI (Kirkegaard & Perry
Laboratories; 1/500).
Measurementofinvolutionoftheipsilateralcerebralhemisphere
volume. Thirty days after stroke, mice were perfused transcardially with 4%
paraformaldehyde,brainswereremovedandcoronalsections(14mm)werestained
with mouse antibodies against NeuN, followed by reaction with biotinylated goat
anti-mouseIgG (Chemicon, Temecula, CA, USA; 1/500),ABC Elite reagent(Vector
Laboratories, Burlingame, CA, USA) and DAB (Sigma-Aldrich Corporation) as
chromogen. The area of the ipsilateral and contralateral cerebral hemisphere
occupied by the neuronal markers, NeuN and MAP2, was calculated using Image J.
8
The ipsilateral and contralateral cerebral hemisphere volume was calculated by
integrating the coronally oriented ipsilateral and contralateral cerebral hemisphere
area as described previously.
8 Involution of the ipsilateral cerebral hemisphere
volume was calculated as (ipsilateral/contralateral cerebral hemisphere volume).
FACS analysis of inﬁltrated lymphocytes into the ischemic
brain. Animals were killed 1 or 7 days after MCO. The ischemic area of the brain
was isolated. Tissues from the four operated mice were incubated with RPMI1640
(Invitrogen), containing 1mg/ml collagenase (Wako Pure Chemical Industries) and
0.1mg/ml DNAse I (Thermo Fisher Scientiﬁc, Waltham, MA, USA), and pressed
through a 40-mm cell strainer
18 (BD Biosciences, Franklin Lakes, NJ, USA). The
mononuclear cells were separated by Ficoll-paque plus (GE Healthcare,
Piscataway, NJ, USA) centrifugation, and labeled with antibody cocktails (Per
CP-CD3 (BD Biosciences), FITC-CD4 (eBioscience), PE-GITR (BD Biosciences)
and APC-CD25 (eBioscience)). Rat IgG2a (eBioscience) was used as control
isotypestaining.Theanalysisofcellswasperformedbyfour-colorﬂowcytometryon
a FACSCalibur (BD Biosciences) using CELLQuest Software (BD Biosciences).
RNA isolation and PCR reaction. Total RNA was isolated from the
cerebral cortex of the infarcted area using ISOGEN (Nippon gene, Tokyo, Japan),
and was treated using Turbo DNA-free kit (Applied Biosystems, Foster city, CA,
USA) in accordance with the manufacturer’s protocol.
Quantity and quality of the isolated RNA was tested by using a Nanodrop 1000
(Thermo Fisher Scientiﬁc).
Quantitative real-time PCR was performed using TaqMan Gene Expression
Assays and the ABI PRISM 7900HT Sequence Detection System (Applied
Biosystems) with Real-time PCR Master Mix (Toyobo, Osaka, Japan). Three
replicates were run for each sample in a 384-well format plate. TaqMan Gene
Expression Assays IDs were described as follows. IFN-g: Mm01168134_m1, TNF-g:
Mm00443258_m1, IL-10: Mm01288386_m1 and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH): Mm99999915_g1.
Conventional RT-PCR was performed using a PC-708 (Astec, Fukuoka, Japan)
with Super Script III One step (Invitrogen). cDNA was ampliﬁed under the following
conditions: 15s at 941C, 30s at 601C and 1min at 681C (35 cycles). PCR products
were analyzed by electrophoresis using Mupid (Advance, Tokyo, Japan). The band
intensity was determined with a LAS-1000 densitometer (Fuji Film, Tokyo, Japan).
Primer sequences were as follows:
nestin, forward 50-CACTAGAAAGCAGGAACCAG-30 and reverse 50-AGATGG
TTCACAATCCTCTG-30;
Sox2, forward 50-TTGGGAGGGGTGCAAAAAGA-30 and reverse 50-CCTGCGA
AGCGCCTAACGTA-30;
GITR,forward50-CCACTGCCCACTGAGCAATAC-30 andreverse50-GTAAAAC
TGCGGTAAGTGAGGG-30;
FasL, forward 50-CTTGGGCTCCTCCAGGGTCAGT-30 and reverse 50-TCTCCT
CCATTAGCACCAGATCC-30; and
GAPDH, forward 50-GGAAACCCAGAGGCATTGAC-30 and reverse 50-TCAGG
ATCTGGCCCTTGAAC-30.
For normalization of real-time data, GAPDH was used as an internal control.
Preparation of induced neural stem/progenitor cells. As described
previously,
6 tissue from the ischemic cortex was mechanically dissociated by
passage through 23- and 27-gauge needles to prepare a single-cell suspension.
The resulting cell suspensions were incubated in a medium promoting formation of
neurosphere-like clusters. Cells were incubated in tissue culture dishes (60mm)
with DMEM/F12 (Invitrogen) containing epidermal growth factor (EGF; Peprotech,
Rocky Hill, NJ, USA; 20ng/ml) and ﬁbroblast growth factor-basic (FGF-2;
Peprotech; 20ng/ml). On day 7 after incubation, neurosphere-like cell clusters
(primary spheres) were formed and were reseeded at a density of 10–15
neurospheres/well in 12-well low-binding plates.
Induction of apoptosis of neural stem/progenitor cells. To study
the effect of TNF-a- or Fas-mediated signaling in vitro, neurospheres were
incubated with TNF-a (R&D systems; 20mg/ml and 100mg/ml) or agonistic anti-
Fas (Jo-2; BD Biosciences; 1mg/ml) containing cycloheximide (CHZ; Sigma-Aldrich
Corporation; 1mg/ml),
40 agonistic anti-GITR (DTA-1; 10mg/ml) or GITR–Fc fusion
protein (6.25mg/ml, Alexis Corporation, Lausen, Switzerland) in DMEM/F12
(Invitrogen)for 24h. Next,theactivity ofcaspase-3was examinedusinga caspase-
3 assay kit (Sigma-Aldrich Corporation) according to the manufacturer’s protocol.
Brieﬂy, neurospheres were homogenized in lysis buffer and centrifuged at 20000g
for 15min. Supernatants were mixed with assay buffer and caspase-3 substrate.
Absorbance at 405nm was measured, and caspase-3 activity was calculated
(n¼3, in eachgroup) usinga spectrophotometer (BeckmanCoulter Inc.,Brea, CA,
USA). Caspase-3 activity was correlated with the protein concentration, which was
determined by the DC protein assay (Lowry method; Bio-rad Laboratories Inc.,
Hercules, CA, USA). To conﬁrm the cells undergoing apoptosis, neurospheres
incubated with these reagents were stained with Annexin V (BD Biosciences), and
were observed under a confocal laser scanning microscope (Carl Zeiss
International, Jena, Germany).
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Cell Death and DifferentiationToexaminetheapoptoticactivityofTcellsinvitro,Tcellswereobtainedfromthe
spleens of mice (several strains) involving CB-17 and gld (FasL deﬁcient) and their
C57/B6 backgrounds,
25 by using a nylon ﬁber column (Wako Pure Chemical
Industries). T cells also were obtained from normal male C57BL/6 (Japan SLC,
Shizuoka, Japan) or C57BL/6-Tg (CAG-EGFP) C14-Y01-FM131Osb transgenic
mice (purchased from RIKEN BRC, Tsukuba, Japan). The T cells were stimulated
with solid phase of anti-CD3e antibody (BDBioscience):T cells wereincubated with
GITR–Ab (DTA-1: 10mg/ml) or control rat IgG (eBioscience) for 48h in RPMI1640
(Invitrogen) in culture plate coated with 10mg/ml of anti-CD3e antibody. Expression
of FasL on GITR-stimulated T cells or non-stimulated T cells was analyzed with
FACS. Each sample was labeled with antibody cocktails (PerCP-CD3, FITC-CD4
and PE-FasL (BD Biosciences)) The analysis of cells was performed by three-color
ﬂowcytometryon aFACSCaliburusingCELLQuestSoftware.Then,1 10
6Tcells
were coincubated with neurospheres in DMEM/F12 (Invitrogen) for 24h (10–15
neurospheres/well in12-well low-bindingplates).Theseneurosphereswerestained
withAnnexinVandobservedwithamicroscope,asmentionedabove.GFP-Tgmice
were purchased from CLEA Japan Inc.
Administration of GITR–Ab or GITR–Fc. GITR–Ab (100mg/mice,
DTA-1; eBioscience), GITR–Fc fusion protein (6.25mg/mice)
16 or rat IgG isotype
control(100mg/mice,eBioscience)was intraperitoneallyadministeredtomiceat3h
and 3 days after stroke.
AdministrationofTcellsintopoststrokeSCIDmice. Tcells(1 10
6
cells/100ml in PBS) obtained from several strains of mice (stimulated or non-
stimulated by GITR-Ab), including CB-17, GFP-Tg, Gld- or C57/B6 mice, were
injected intravenously into SCID mice at 48h after stroke. Mice were subjected to
histological examination after stroke. In another experiment, their brains were
utilized for PCR analysis of nestin and Sox2.
Statistical analysis. Results were reported as the mean standard deviation.
Statistical comparisons among groups were determined using one-way analysis of
variance. Where indicated, individual comparisons were performed using Student’s
t-test. The groups with Po0.01 or, in some cases, Po0.05 differences were
considered signiﬁcant.
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